The inclusion of Al Noor helped Mediclinic International grow revenue for the six months to end-September 27% to £1.28bn, the group reported on Thursday.
Al Noor contributed 16% of revenue growth, Mediclinic said in its interim results statement.
The combined group’s aftertax profit grew 14% to £117m.
Mediclinic declared a 3.2 pence interim dividend, 20% higher than the matching period’s 2.66p.
Its Southern African hospitals grew revenue 8% to R7.28bn, which translated into 4% revenue growth to £364m.
In SA and Namibia, Mediclinic operated 52 hospitals and two day clinics with a total of 8,043 beds and 17,031 employees. This made it the third-largest private healthcare provider in Southern Africa, the results statement said.
Its bed occupancy rate in Southern Africa increased to 74.2% from 73.6% in the previous period. Revenue per bed day grew 5.5%.
Its Middle East operations more than doubled revenue to 1.55-billion United Arab Emirates dirham, which translated into 137% growth to £306m revenue.
This jump was mainly due to the acquisition of Al Noor on February 15.
At September 30, Mediclinic operated five hospitals, with a sixth opening soon in Al Ain, and 37 clinics with a total of 687 beds and 6,715 employees, making it the largest private healthcare provider in the United Arab Emirates.
Mediclinic’s biggest revenue contributor is its Swiss subsidiary Hirslanden.
Thanks to the pound’s crash after Brexit, Hirslanden’s 5% revenue growth to Sf819m translated into 15% revenue growth to £613m for the group.
Hirslanden operates 16 hospitals and four clinics with a total of 1,677 inpatient beds and 9,342 employees.